https://www.selleckchem.com/pr....oducts/trastuzumab-d
Ovarian cancer (OC) has the highest mortality among gynecological malignancies. Therefore, it is urgent to explore prognostic biomarkers to improve the survival of OC patients. One of the most prominent metabolic characteristics of cancer is effective glycolysis. Hexokinase 1 (HK1), as the first rate-limiting enzyme in glycolysis, is closely related to cancer progression. However, the role of HK1 in OC remains unclear. The Cancer Genome Atlas (TCGA) database was used to detect the expression of in OC patients. The chi-squ
Me gusta
Comentario
Compartir
